K H Wiesmüller1, B Fleckenstein, G Jung
1EMC microcollections GmbH, Tübingen, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Synthetic immunogens offer a novel approach to vaccine development by incorporating immune-stimulating properties. These minimal vaccines bypass the need for carriers or adjuvants, simplifying vaccine design and enhancing immune responses.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: